Skip to main content
. 2022 Jul 19;162(6):1241–1254. doi: 10.1016/j.chest.2022.07.008

Table 5.

Latent Class Model Results

Attribute Parameter (Level) Class 1a (Predicted Share, 43%b)
Class 2 (Predicted Share, 47%)
Class 3 (Predicted Share, 10%)
Marginal Effect 95% CI Marginal Effect 95% CI Marginal Effect 95% CI
Opt-out constant 0.58 –0.81 to 1.98 –0.72 –1.7 to 0.25 4.30c 2.16 to 6.44
Lung function Modest deterioration (–5%) –0.11 –0.98 to 0.75 –1.11c –1.64 to –0.57 –0.92 –1.91 to 0.06
No change Referent
Modest improvement (+5%) 0.97d 0.11 to 1.83 0.97c 0.6 to 1.35 0.2 –0.78 to 1.19
Excellent improvement (+15%) 1.85e 0.7 to 3 1.73c 1.16 to 2.31 0.83 –0.35 to 2.01
Need for IV antibiotics No change Referent
One-half the number of IV courses 0.27 –0.24 to 0.78 0.52c 0.27 to 0.77 –0.21 –0.83 to 0.42
Abdominal symptoms No change Referent
Improvement in symptoms –0.09 –0.68 to 0.5 0.57e 0.23 to 0.91 0.17 –0.58 to 0.93
Improvement in symptoms and a reduction in pancreatic enzymes 0.21 –0.35 to 0.77 0.67c 0.32 to 1.02 0.34 –0.47 to 1.15
Life expectancy No change Referent
Increases by 5 y 1.85c 0.94 to 2.75 0.49 –0.02 to 1.01 1.79e 0.45 to 3.12
Increases by 10 y 4.79c 3.57 to 6.02 1.49c 0.96 to 2.01 2.45e 1.04 to 3.86
Increases by 15 y 6.62c 5.08 to 8.16 1.71c 1.1 to 2.32 3.05c 1.51 to 4.59
Overall quality of life No change Referent
Good improvement (+10%) 0.89c 0.37 to 1.42 0.29 0 to 0.58 0.46 –0.35 to 1.27
Excellent improvement (20%) 1.14c 0.57 to 1.71 0.9c 0.56 to 1.25 0.72 –0.08 to 1.52
Use of inhaled medicines No change Referent
A modest reduction in time spent (25%) 0.24 –0.37 to 0.85 0.20 –0.11 to 0.5 1.13e 0.29 to 1.97
A large reduction in time spent (50%) 0.95e 0.41 to 1.49 0.34e 0.03 to 0.65 0.99e 0.08 to 1.9
Physiotherapy/ACT No change Referent
Time spent on physiotherapy is halved 0.53e 0.02 to 1.04 0.17 –0.1 to 0.45 0.45 –0.32 to 1.22
Able to fully stop physiotherapy 0.71 –0.17 to 1.59 0.80c 0.47 to 1.13 0.91e 0.08 to 1.74
Model statistics No. of observations, 3,708; McFadden R2, N/A; LL, –697; AIC, 1,501; BIC, 1,831

ACT = airway clearance therapy; AIC = Akaike information criterion; BIC = Bayesian information criterion; LL = log likelihood; N/A = not applicable.

a

As marginal effects are calculated relative to the reference level for each class, they are not directly comparable across classes; the ratios between effects, however, may be directly compared.

b

Probability of class membership equates to percentage class share of the population.

c

P < .001.

d

P < .1.

e

P < .05.